We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJTOW.L Regulatory News (JTOW)

  • There is currently no data for JTOW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

J2 Acquisition Limited to Acquire APi Group, Inc.

3 Sep 2019 07:00

RNS Number : 9722K
J2 Acquisition Limited
03 September 2019
 

J2 Acquisition Limited to Acquire APi Group, Inc. for $2.9 Billion

 

A Market Leading Provider of Commercial Life Safety Solutions

and Industrial Specialty Services

 

Tortola, British Virgin Islands, Sep. 3, 2019 - J2 Acquisition Limited ("J2", LSE: JTWO) announced today that it has entered into a definitive agreement to acquire APi Group, Inc. ("APi" or "Company"), a market-leading provider of commercial life safety solutions and industrial specialty services, for approximately $2.9 billion, subject to customary closing conditions (the "Transaction"). J2 expects to list its shares on the New York Stock Exchange ("NYSE") under the symbol APG and change its jurisdiction of incorporation to Delaware in connection with the NYSE listing.

 

APi is a market-leading provider of commercial life safety solutions and industrial specialty services and a top-5 specialty contractor in the U.S. with a diversified, blue chip customer base, robust contracted services offering, and a track record of successful acquisitions. The Company operates more than 40 nationally and regionally significant businesses with market-leading brands in over 200 locations and generates over 95% of its revenue in North America, primarily in the United States. APi has historically delivered consistent and strong financial results and expects to deliver approximately $4 billion in revenue and approximately 10% adjusted EBITDA margins for the full year 2019.

 

APi provides J2 an ideal foundation of market leadership upon which to build through a prudent strategy that prioritizes organic growth, combined with strategic and opportunistic M&A. The J2 founders Martin E. Franklin, James E. Lillie, and Ian G.H. Ashken, have decades of experience operating, growing, and investing in multiple businesses using a similar strategy focused on organic growth and disciplined acquisitions in niche markets and industries, as well as on building winning cultures. APi, with approximately 15,000 employees, has an industry leading employee development program and, following its investment in APi, J2 plans to continue to build on APi's operating strengths with a focus on expanding the service portion of the business across its portfolio.

 

Sir Martin E. Franklin, co-founder of J2, commented, "We believe APi is an excellent foundation for J2's initial investment and is solidly in line with our disciplined investment criteria. The Company demonstrates similar qualities to Jarden, in that it unlocks uncommon value from niche businesses and delivers a strong track record of consistent organic performance complemented by disciplined M&A. This Transaction meets our long established acquisition criteria with significant potential for short and long term value creation for our shareholders. We look forward to working with Russ Becker, the President and CEO of APi, whose leadership has positioned the Company for the strong growth opportunities ahead."

 

James E. Lillie, co-founder of J2, added, "We were immediately impressed by APi's management team, its strong culture, and its commitment to leadership development, combined with consistent delivery of margins and cash flow at the high end of its peer group over the years. The business operates in resilient and dynamic markets with attractive growth drivers and we believe that, with the current management team, we can drive shareholder value by guiding the business to even better levels of performance and growth. We expect APi to deliver long-term value creation through above industry average organic sales growth, its ability to leverage SG&A, expansion of Adjusted EBITDA margins to 12%+ by 2023, continued free cash flow conversion of 80%+, high single digit average earnings growth and maintenance of a long term leverage ratio of 2.0x-2.5x."

 

APi's existing management team will remain in place, including President and CEO Russell A. Becker and Thomas Lydon, who upon closing will become the combined company's CEO and CFO respectively. Martin E. Franklin and James E. Lillie will become Co-Chairmen of the Company, Ian G.H. Ashken and Russell Becker will join the board along with a number of other board additions to be announced at closing of the Transaction. J2 intends to change its name to APi Group Corporation upon closing.

 

Russell A. Becker, President and CEO of APi, commented, "The J2 team's decades of leadership experience operating large diverse businesses, broad industrial knowledge, and disciplined acquisition strategy - that they have employed successfully at previous companies and ventures - will be instrumental in further growing APi's inherent value and innovative, customer-centric approach over the long term. The J2 team's approach has historically produced impressive results and opportunities for shareholders, customers, suppliers, the communities in which they operate, and importantly, for employees, and is highly complementary to APi's existing culture and strategy. We look forward to benefitting from J2's successful operating experience and investment knowledge. Additionally, I want to thank Lee Anderson for his 55+ years of service at APi. Our tremendous growth and unique culture would not have been possible without his leadership, commitment, sacrifice and complete dedication to APi."

 

The Chairman of the J2 Board of Directors, Lord Myners of Truro CBE stated "The J2 Board unanimously supports this transaction. We believe APi is an excellent fit with J2 and congratulate the founders of J2 and the management team of APi."

 

The Transaction is expected to be funded through a combination of J2's cash on hand, new debt financing, early warrant exchange (as described below), and rollover equity from existing shareholders. For Transaction valuation purposes, Russell Becker's investment of 50% of his net sale proceeds and other existing shareholders rollover equity is valued at $10.25 per share, the same price as the Warrant Financing. Current APi shareholders will receive approximately $2.05 billion in cash and 28.373 million ordinary shares in J2 and will own approximately 14.5% of the company at closing, primarily held by the Company's existing employee stock ownership plan. The Company's net debt leverage ratio at closing is expected to be 2.8x, assuming the full warrant exercise.

 

The Transaction includes a tax asset with a net present value of approximately $180 million, resulting in a net purchase price multiple of 7.4x last-twelve-months June 30, 2019 Adjusted EBITDA of $371 million. The Transaction is expected to close in the fourth quarter of 2019, subject to customary closing conditions.

 

It is expected that the listing of the ordinary shares and warrants on the standard segment of the Official List will be suspended by the UK Financial Conduct Authority at J2's request with effect from 7.30 a.m. (London time) on 3 September 2019, as, in accordance with the requirements of the UK Listing Rules, the Transaction is treated as a reverse takeover. Trading of the ordinary shares and warrants on the London Stock Exchange (the "LSE") is expected to be suspended from this time and it is not expected that trading will resume. However, shares may trade on the OTC market in the U.S. under the symbol JJAQF. It is anticipated that J2's listing of shares and warrants on the LSE will be cancelled on or shortly after the NYSE listing is achieved.

 

J2 expects shortly to announce an early warrant exercise financing (the "Warrant Financing") and consent solicitation to replace part of the committed debt funding as part of the Transaction. Warrant holders will be given the opportunity (i) to commit to the early exercise of their warrants, conditional upon consummation of the Transaction, at a reduced exercise price of $10.25 per whole ordinary share (the "Reduced Exercise Price"), and (ii) to consent to an amendment to shorten the subscription period for the warrants to expire upon the consummation of the Transaction (subject to certain limited exceptions) (the "Warrant Amendment"). In order to participate in the Warrant Financing at the Reduced Exercise Price, warrantholders must also consent to the Warrant Amendment (unless and until such time that J2 announces that the Warrant Amendment has been effected, following which all warrantholders may participate in the Warrant Financing at the Reduced Exercise Price). Each of (i) Mariposa Acquisition V, LLC, a Delaware limited liability that is affiliated with Martin E. Franklin, James E. Lillie, and Ian G.H. Ashken representing approximately 8.0% of all outstanding warrants, and (ii) entities managed by Viking Global Investors LP, representing approximately 20% of all outstanding warrants, have committed to exercise all of their warrants in connection with the Warrant Financing at $10.25 per ordinary share, representing approximately $34.1 million and $85.4 million, respectively, and consent to the Warrant Amendment.

 

Please refer to Annex 1 for more financial information on APi and Annex 2 for certain pro forma financial information.

 

UBS Investment Bank acted as financial advisor, Citigroup as capital markets advisor and Greenberg Traurig acted as legal advisor to J2 on this Transaction. Citigroup, Bank of America, Barclays and UBS have committed to provide financing for the Transaction.

 

William Blair & Company acted as financial advisor and Faegre Baker Daniels and Fredrikson & Byron acted as legal advisors to the Company on this Transaction.

 

Conference Call Information:

Dial in Number:

1-877-830-2596 (U.S.)

1-785-424-1743 (International)

Conference ID:

93112

Webcast Link:

https://event.on24.com/wcc/r/2075263-1/CCFE25D84727E8842EDFB66448727F26

 

Forward-Looking Statements and Disclaimers:

APi's financial information contained herein is derived from APi's historical financial statements (the "APi Historical Financial Statements"). APi's Historical Financial Statements have historically been prepared based on the U.S. accounting standards and principles applicable to private companies. Following the completion of the Transaction, APi's Historical Financial Statements will be revised to comply with U.S. GAAP applicable to public companies (such revised Target Historical Financial Statements being referred to herein as the "Public Company Financial Statements"). The Public Company Financial Statements, which have not yet been finalized, may differ materially from, and may not be comparable to, APi's Historical Financial Statements. The Public Company Financial Statements may not be reflective of, and may differ materially from, the financial position or results of operations of APi as set forth in the Target Historical Financial Statements.

 

This announcement does not constitute or form part of any offer or invitation to purchase, otherwise acquire, issue, subscribe for, sell or otherwise dispose of any securities, nor any solicitation of any offer to purchase, otherwise acquire, issue, subscribe for, sell, or otherwise dispose of any securities.

 

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

 

Certain statements in this announcement are forward-looking statements which are based on J2's expectations, intentions and projections regarding the Company's future performance, anticipated events or trends and other matters that are not historical facts, including expectations regarding: (i) the anticipated closing date of the Transaction; (ii) the ability of J2 to consummate the debt financing and the Warrant Financing (including effecting the Warrant Amendment); (iii) the ability of J2 to effect the NYSE listing; (iv) the future operating and financial performance of APi, including expectations regarding revenue and adjusted EBITDA margins in 2019, (v) the ability to drive shareholder value and estimates of organic growth, SG&A, target operating Adjusted EBITDA margins, free cash flow conversion, average earnings growth and long term leverage ratios, (vi) the post-closing composition of the board of directors, (vii) the anticipated sources of funding the purchase price and (viii) the anticipated post-closing net debt ratio. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i) economic conditions, competition and other risks that may affect APi's future performance; (ii) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreement entered into among the parties thereto in connection with the acquisition (the "Transaction Agreement"); (iii) the risk that securities markets will react negatively to the Transaction or other actions by J2, APi and/or the combined company after completion of the Transaction; (iv) the risk that the Transaction disrupts current plans and operations as a result of the announcement and consummation of the Transaction described herein; (v) the ability to recognize the anticipated benefits of the combination of J2 and APi and of the combined company to take advantage of strategic opportunities; (vi) costs related to the Transaction; (vii) the limited liquidity and trading of J2's securities; (viii) changes in applicable laws or regulations; (ix) the possibility that J2 or APi may be adversely affected by other economic, business, and/or competitive factors; and (x) other risks and uncertainties.

 

Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, neither J2 nor APi undertake any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Nothing in this announcement constitutes or should be construed as constituting a profit forecast.

 

This announcement contains inside information as defined in article 7 of the Market Abuse Regulation (EU) No 596/2014.

 

About APi:

 

APi Group Inc. ("APi") is a market leading provider of commercial life safety solutions and industrial specialty services. With a national and regional focus, the Company operates three segments in over 200 locations across the U.S., Canada, and the UK. APi is the leading independent life safety services provider and a top-5 specialty services contractor in the U.S. with a diversified, blue chip customer and supplier base, a robust service offering, and a track record of successful acquisitions. More information can be found at https://www.apigroupinc.com/.

 

About J2:

 

J2 Acquisition Limited (LSE: JTWO) is a publicly-listed acquisition company that listed in October 2017 to undertake an acquisition of a target company. More information on J2 is available at http://www.j2acquisitionlimited.com/access-gateway

 

Media Contacts:

 

Liz Cohen

Kekst CNC

+1 212-521-4845

Liz.Cohen@kekstcnc.com

 

 

 

Annex 1:

 

Adjusted EBITDA Reconciliation

LTM

($ in millions)

2016

2017

2018

6/30/2019

Reported Net Income

$103.8

$112.4

$122.5

$133.2

Adjustments to reconcile to net income (loss)

Interest (income)/expense

5.1

8.3

22.1

25.9

Foreign & state income taxes

8.8

8.1

10.4

10.6

Depreciation and amortization

92.0

97.3

132.7

139.7

Earnout expense (1)

18.2

5.6

28.9

28.5

Timing adjustments (2)

(23.6)

1.1

(5.8)

(5.4)

Prior ownership change adjustments (3)

23.2

30.9

30.2

29.1

Non-cash compensation

9.1

10.2

3.5

3.0

Non-recurring expenses

0.1

15.0

6.2

5.8

Pro-forma acquisition adjustments (4)

73.7

52.3

-

-

Adjusted EBITDA

$310.3

$341.1

$350.7

$370.5

 

Notes:

1. Reflects contingent consideration paid based on financial performance of acquired businesses.

2. To reflect year end timing adjustments on a like-for-like basis.

3. Includes normalization of costs that would cease post-closing.

4. Represents the pro forma EBITDA that would have been generated from acquired entities had they been acquired as of January 1.

 

 

Annex 2:

 

Pro Forma Earnings Per Share for J2 Based on Standalone APi

($ in millions, except per share value)

Adjusted EBITDA (1)

$370.5

Depreciation & amortization

73.1

Annualized interest expense (2)

54.0

Tax (as adjusted tax rate of 23%) (3)

56.0

Adjusted Net Income

187.4

Diluted shares outstanding (4)

195.1

Adjusted EPS

$0.96

 

Notes:

1. Please see above EBITDA reconciliation.

2. Represents 2019 annualized full-year interest expense based on 10/1/19 close, debt of $1,080 million, and an effective rate of 5.0%.

3. Adjusts the expected GAAP effective tax rate to take account of the long-term annualized cash tax benefit of the Company's tax asset arising from the transaction with APi.

4. Assumes early exercise of 100% of warrants and issuance of J2 shares as part of the purchase consideration, both at $10.25 per share.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQUGUQWBUPBGRP
Date   Source Headline
29th May 20203:55 pmRNSAPi Announces Cancellation of Listing from LSE
30th Apr 20207:00 amRNSTR-1 - Notification of major holdings
30th Apr 20207:00 amRNSTR-1 - Notification of major holdings
29th Apr 202012:00 pmRNSAPi Announces Commencement of Trading on NYSE
27th Apr 20207:00 amRNSAPi Announces Anticipated Listing Date on NYSE
9th Apr 20207:00 amRNSAPi Group Reports 4Q and FY 2019 Financial Results
24th Dec 201912:30 pmRNSAPi Group Announces Confidential Submission of S-4
20th Nov 20192:15 pmRNSAPi Group Announces DTC Settlement Eligibility
20th Nov 201912:30 pmRNSAPi Reports Third Quarter and Nine Month Results
16th Oct 20197:00 amRNSAPi Announces Anticipated Settlement Eligibility
9th Oct 20197:00 amRNSChange of ISINs and SEDOLs
4th Oct 201911:30 amRNSTR-1 - Notification of major holdings
3rd Oct 20192:00 pmRNSTR-1 - Notification of major holdings
3rd Oct 20192:00 pmRNSTR-1 - Notification of major holdings
3rd Oct 20192:00 pmRNSAPi Group Corporation - PDMR Notification
2nd Oct 20197:00 amRNSTotal Voting Rights and Share Capital Information
1st Oct 20194:57 pmRNSJ2 Acquisition Completes Acquisition of APi Group
1st Oct 20197:00 amRNSSecured Debt Credit Facilities Successful Results
24th Sep 20197:00 amRNSClosing Notice Announcement
17th Sep 20194:26 pmRNSWarrant Financing Consent Solicitation Update
3rd Sep 201911:25 amRNSLaunch of Warrant Financing / Consent Solicitation
3rd Sep 20197:00 amRNSJ2 Acquisition Limited to Acquire APi Group, Inc.
16th Aug 201912:07 pmRNSSecond Price Monitoring Extn
16th Aug 201912:02 pmRNSPrice Monitoring Extension
14th May 20194:30 pmRNSHalf-year Report
28th Feb 20194:42 pmRNSSecond Price Monitoring Extn
28th Feb 20194:36 pmRNSPrice Monitoring Extension
2nd Jan 20194:46 pmRNSSecond Price Monitoring Extn
2nd Jan 20194:36 pmRNSPrice Monitoring Extension
13th Nov 20181:50 pmRNSAnnual Financial Report
16th May 20182:30 pmRNSHalf-year Report
9th Feb 20184:41 pmRNSSecond Price Monitoring Extn
9th Feb 20184:36 pmRNSPrice Monitoring Extension
28th Dec 20174:40 pmRNSSecond Price Monitoring Extn
28th Dec 20174:35 pmRNSPrice Monitoring Extension
16th Oct 20173:31 pmRNSNotification of major holding TR1
12th Oct 20171:15 pmRNSHolding(s) in Company
10th Oct 20177:00 amRNSAdmission to Trading on the London Stock Exchange
5th Oct 20174:02 pmRNSPublication of a Prospectus
5th Oct 20177:00 amRNSResults of IPO of J2 Acquisition Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.